scispace - formally typeset
Open AccessJournal ArticleDOI

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

TLDR
The reported incidence of sepsis is increasing, likely reflecting aging populations with more comorbidities, greater recognition, and, in some countries, reimbursement-favorable coding.
Abstract
Sepsis, a syndrome of physiologic, pathologic, and biochemical abnormalities induced by infection, is a major public health concern, accounting for more than $20 billion (5.2%) of total US hospital costs in 2011.The reported incidence of sepsis is increasing, likely reflecting aging populations with more comorbidities, greater recognition, and, in some countries, reimbursement-favorable coding. Although the true incidence is unknown, conservative estimates indicate that sepsis is a leading cause of mortality and critical illness worldwide. JMS 2015;18(2):162-164

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Andrew Rhodes, +58 more
TL;DR: Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.
Journal ArticleDOI

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

TL;DR: A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in CO VID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism, but its efficacy remains to be validated.
Journal ArticleDOI

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

TL;DR: The panel of experts, having emphasised the importance of initiating aetiologic treatment for any degree of hepatic disease at the earliest possible stage, extended its work to all the complications of cirrhosis which had not been covered by the European Association for the Study of the Liver guidelines.